Study summary

A study of ASP2151 in subjects with recurrent outbreaks of genital herpes.

Additional Study Details

Phase
2
Product
N/A
Product
ASP2151
valacyclovir
Placebo
Type
Interventional
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Enrollment number
695
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A Study with ASP2151 in Subjects with Recurrent Episodes of Genital Herpes? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    Indianapolis, IN, United States, 46202
    Completed
    Omaha, NE, United States, 68134
    Completed
    Portland, Oregon, United States, 97210
    Completed
    San Diego, California, United States, 92108
    Completed
    Albuquerque, NM, United States, 87131
    Completed
    Baltimore, MD, United States, 21201
    Completed
    Denver, CO, United States, 80262
    Completed
    Miami, FL, United States, 33156
    Completed
    Phoenix, AZ, United States, 85015
    Withdrawn
    Chicago, Illinois, United States, 60612
    Completed
    Houston, TX, United States, 77058
    Completed
    Sacramento, CA, United States, 95821
    Completed
    Philadelphia, PA, United States, 19103
    Completed
    Birmingham, AL, United States, 35294
    Completed
    Houston, TX, United States, 77030
    Completed
    Salt Lake City, UT, United States, 84132
    Completed
    Tucson, AZ, United States, 85712
    Completed
    Seattle, WA, United States, 98122
    Completed
    Boynton Beach, FL, United States, 33472
    Completed
    Annandale, Virginia, United States, 22003
    Terminated
    Madisonville, KY, United States, 42431
    Completed
    Los Angeles, CA, United States, 90017
    Completed
    Atlanta, Georgia, United States, 30328
    Completed
    Arlington, TX, United States, 76011
    Completed
    Billings, MT, United States, 59101
    Completed
    Westlake Village, CA, United States, 91361

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?